Location: Yerevan
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Yerevan
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study Phase N/A · S. Malayan Eye Center · Sanoculis Ltd · NCT06577857 Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery Phase 3 · Yeolyan Hematology and Oncology Centre · Octapharma · NCT04918173 Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Phase N/A · Hematology Center after Prof. Yeolyan · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149 Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens Phase N/A · Nikomed Medical Center · Nikomed Medical Center · NCT05935189 Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Co Phase 2 · Center of Medical Genetics and Primary Health Care LLC · R-Pharm International, LLC · NCT05190991 Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry Phase N/A · Hematology Center named after prof. R. Yeolyan · Immune Oncology Research Institute · NCT05430971 EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography NA · Erebouni Medical Center · Santiago Ortega Gutierrez · NCT07001852 Chronic Coronary Syndrome Snapshot Study Phase N/A · Erebouni Medical Center · European Society of Cardiology · NCT06748924 ColoSeal™ ICD System Safety and Feasibility Study NA · National Center of Oncology after V.A. Fanarjian · Averto Medical, Inc. · NCT06402188 A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Phase 3 · Site 101001 · mAbxience Research S.L. · NCT06687369 Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impa Phase 1 · Erebuni Medical Center · Taiho Oncology, Inc. · NCT04953897 A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas® Phase 1 · "Tonus-Les" LLC · Berlin-Chemie AG Menarini Group · NCT07156916 Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids Phase 1/Phase 2 · Yeolyan Hematology. , and Oncology Center - · Shionogi · NCT05588323 Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Tre Phase 3 · Octapharma Research Site · Octapharma · NCT06361537 Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases Phase N/A · Hematology Center after Prof.R.H. Yeolyan · Santé Arménie French-Armenian Research Center · NCT05904301 Cardiac Angiosarcoma International Registry Phase N/A · Yeolyan Hematology and Oncology Center · Immune Oncology Research Institute · NCT06715579 CAYA Cancer Retrospective Cohort Study Phase N/A · Yeolyan Center for Cancer and Blood Disorders · Resonance, Inc. · NCT07246213 PVEK Corneal Implant For Treatment of Corneal Edema Phase 1 · Ophthalmological Center After S.V.Malayan · Precise Bio · NCT07325097 Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Im Phase 1 · Erebuni Medical Center · Taiho Oncology, Inc. · NCT04953910 Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries Phase N/A · Real World Real People · Médecins du Monde · NCT06395129 Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 in Pregnancy and Pre-Eclampsia NA · N2 · Withings · NCT07595016 A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis Phase 3 · "ARABKIR" Joint Medical Center & Institute of Child and Adol · Genexine, Inc. · NCT06466785 Clinical Epidemiology in Contemporary Patients With Myelofibrosis. Phase N/A · Hematology Center after Prof.R.H. Yeolyan · FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · NCT06533813 CAYA Cancer Prospective Cohort Study Phase N/A · Yeolyan Center for Cancer and Blood Disorders · Resonance, Inc. · NCT07632014 Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania EARLY_Phase 1 · National Institute for Infectious Diseases · Médecins du Monde · NCT06159504 Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care Phase 1/Phase 2 · Yerevan medical scientific center · 4TEEN4 Pharmaceuticals GmbH · NCT06832722 Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001) Phase 2 · Hematology Center named after prof. R. Yeolyan · Immune Oncology Research Institute · NCT05891821 A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non Phase 2 · Ophthalmological Center After S.V. Malayan · Galimedix Therapeutics Inc · NCT06659549 Rare Embryonal Tumors of the Central Nervous System: International Registry Phase N/A · Hematology Center named after prof. R. Yeolyan · Immune Oncology Research Institute · NCT05711992
Look up another city
Look up another condition